'Congress' Is Not Flailing. Republicans Are. With whom,

New Post Public Reply Private Reply Replies (2) Message Board
Bhawks
280
'Congress' Is Not Flailing. Republicans Are.

With whom, exactly, are the Democrats supposed to negotiate here in Bedlam?

No, goddammit, Washington Post, Enough of this nonsense.




https://www.esquire.com/news-politics/politic...nl21062466

“Congress” is not flailing. The Republican majority in the Senate is flailing, because the Republican majority is made up of Republicans, and the Republican Party is made up of hyper-ambitious lunatics.

It’s not “Congress” that’s stiffing the millions of Americans who need relief in this perilous time of tangled national emergencies that are feeding off each other. It’s the Republicans. Why is that so hard to say?

The crisis that forced lawmakers to act with unusual speed in March and April to pump an unprecedented $3 trillion into the economy has not abated. By some measures, after a brief leveling off in infections and some positive economic indicators, things have gotten worse.

What has faded is the sense of bipartisan urgency that existed in the spring and propelled Congress to act with near unanimity. At that time, the new virus that was wreaking economic havoc around the nation was so alarming it seemed to startle lawmakers out of their partisan corners. But now the election is nearing, and the novel coronavirus is not so novel. The partisan divisions are back on Capitol Hill, and they appear to be as intractable as ever.

Oh, FFS, as all the kidz abbreviate these days. The Democratic House has passed a relief package that deals with all aspects of the current crises, from aid to schools to help for the states with balloting this November.

But the Republican president* is in Cloud Cuckoo Land on the pandemic, and the Republicans in the Senate, desperate to hold onto their majority, can’t figure out if there are more votes to be had by helping the folks back home, or by pumping more hot-air into the leaky balloon of “fiscal responsibility.” And Mitch McConnell has so lost control of his caucus that he went home this past weekend having accomplished nothing.

Senate Majority Leader Mitch McConnell (R-Ky.) waited months over the late spring and summer to act, saying he wanted to see what impact the programs already approved were having before agreeing to anything more. During that time the virus itself frustrated widespread hopes that the situation might improve and began to surge in states that had reopened too aggressively.

McConnell finally released a $1 trillion bill last Monday as the GOP’s answer to the much larger bill passed by House Democrats in May, but he struggled to get consensus within his party and with the Trump administration, including complaints from members of his own conference about everything from the price tag to a new round of stimulus checks.

Between the people afraid of losing their seats, and the senators who want to run for president in 2024, McConnell is paralyzed. Of course, you will never guess what the real problem is.


Democrats have consistently rejected the notion of a short-term fix, and in face of the GOP’s disunity they have shown little willingness to compromise on their push for the most generous relief bill possible, with an array of provisions that Republicans reject, such as $1 trillion in new aid for cities and states. Republicans say they do not think Democrats want to pass anything at all because they’d rather have a political issue; Democrats angrily reject that accusation.

Yes. Yes, they do. You know why? Because it’s bullshit, that’s why. McConnell can’t even get his caucus to listen to either the White House chief of staff or the Secretary of the Treasury, let alone himself. With whom, exactly, are the Democrats supposed to negotiate here in Bedlam?

“Our politics is such that there must be significant political pain before hard things can get done,” said Brendan Buck, who was a top adviser to former Republican House speaker Paul D. Ryan. “That’s our forcing mechanism, and the political pain will be starting very soon.”

Just shut up, OK? It’s not “our politics,” dude. It’s your politics. Own it.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Radiation Oncology Text Earns Doody's 2026 Nod

Updated Category News Views 24

Recognition in Radiation Oncology In the rapidly advancing arena of radiation oncology, staying current is no small feat. But here's a feather in the cap of one publication doing just that: Fundamentals of Radiation Oncology: Physical, Biological, and Clinical Aspects, 4th Edition. This resource has made quite the splash by snagging a spot on the 2026 Doody's Core Titles...

Continue Reading
Curis Prepares for Q3 2026 Results Amid Tough Sector Trends

Updated Category News Views 139

All Eyes on Curis as Q3 Financials Loom Just when you think you’ve seen it all in this wild biotech ride, Curis, Inc. (NASDAQ: CRIS) is prepping to roll out their third quarter financial and operating results. Circle your calendars for November 12, 2026, because the clock’s ticking down to their 4:00 p.m. ET announcement, swiftly followed by a conference call at 4:30...

Continue Reading
Home Insurance Depreciation and What it Means for You

Updated Category News Views 17

A Deep Dive into Depreciation's Impact on Home Insurance Folks, if you haven't battled the insurance beast, you're missing out on an unholy mess. Let's talk about something that's been quietly gnawing at homeowners’ wallets—depreciation in home insurance claims. Peggy Schneider, an insurance guru from Kalispell, Montana, lays it all out in HelloNation, and I'm here to...

Continue Reading
FDA Greenlights Halozyme's Cancer Treatment Breakthrough

Updated Category News Views 18

FDA's Seal of Approval: A Game Changer Well, folks, here's a twist in the story of cancer treatment with FDA giving a nod to RYBREVANT FASPRO. Johnson & Johnson's latest offering, fueled by Halozyme's groundbreaking ENHANZE technology, just snagged accelerated approval. We're not just talking any old treatment here; it's a dual-targeted therapy for head and neck cancer...

Continue Reading
Birth Registration Revolution: OSIA Interoperability Demo

Updated Category News Views 86

Bringing Birth Registration into the 21st Century Alright, let's cut through the fog. If you ask most folks about their birth certificates, you'd hear tales of tattered paper and government office runs. What if I told you this vital piece of paper could be reborn altogether? That's what the Secure Identity Alliance is up to with their OSIA Live Interoperability Demo at...

Continue Reading
TELUS Boosts Board with Strategic Executive Appointments

Updated Category News Views 47

New Faces on the TELUS Board: Shaping the Future Alright, investors, here's the scoop straight from the trenches: TELUS (TSX:TU) is shaking things up at the top. Marc Allera and Bill Thomas are stepping into the fray as the newest members of the board, effective January 1, 2027. If you're not familiar with these names, it's time to tune in because they've got the chops to...

Continue Reading
Encompass Health Faces Uncertain Future with Sea Pines

Updated Category News Views 68

Unexpected Downpour Closes Sea Pines They say when it rains, it pours. That's not just true in life, but as it happens, it's quite literal in Melbourne, Florida. A deluge of biblical proportions forced an immediate lockdown of the Sea Pines Rehabilitation Hospital. Flooded to the gills, this once stalwart institution finds its doors shuttered indefinitely. It's a...

Continue Reading
Bowling Makes a Strike at Macy's 100th Parade in NYC

Updated Category News Views 64

Rolling with Tradition: Bowling at Macy's Parade Back in the day, bowling wasn't exactly the sport making headlines. But times, they change. Here we are in the thick of things, witnessing Go Bowling getting its moment in the spotlight during the historic 100th Macy's Thanksgiving Day Parade®. It's not about raking in the dough or hitting some stocks; it’s about...

Continue Reading
PPL Reports Strong Q3; Long-Term EPS Growth Up

Updated Category News Views 29

Solid Earnings in a Challenging Market Anytime you start hearing a company like PPL boasting about their quarterly earnings, it's time to sit up straight and pay attention. The utility giant didn’t just match expectations, they beat 'em, clocking in with $0.54 per share in ongoing earnings for Q3 2026, up from $0.48 the previous year. Not a bad step forward if you ask...

Continue Reading
Tucows Shows Progress in Q3 2026 Amidst Net Loss

Updated Category News Views 140

Q3 Snapshot: Balancing Act at Tucows Man, if there's one thing you can count on from Tucows, it's that they'll shuffle the deck just when you're getting comfortable. Here in the third quarter of 2026, they've managed a decent juggling act. Their unaudited numbers show consolidated net revenue ticking up 1.4% from last year, rounding out at a cool $100 million. That's...

Continue Reading

Top 5 Most Recently Viewed Articles

Nicole Kidman's New Role as Clé de Peau Beauté Ambassador

Updated Category News Views 302

Nicole Kidman Joins Clé de Peau Beauté as Global Brand Ambassador The renowned and celebrated Hollywood actress, Nicole Kidman, has taken on a monumental role as the new Global Brand Ambassador for Clé de Peau Beauté, a brand recognized for its luxurious skincare and makeup offerings. Kidman's exceptional presence in the entertainment industry transcends mere stardom;...

Continue Reading
Future FinTech Group Unveils Innovative AI Trading Platform

Updated Category News Views 171

Future FinTech Group Launches AI-Powered Trading Platform Future FinTech Group Inc. (NASDAQ: FTFT), known for its comprehensive financial and digital technology services, has initiated an exciting endeavor with its subsidiary, FTFT International Securities & Futures Co., Ltd. ("Future Securities"). This strategic move aims to revolutionize investment analytics and trading...

Continue Reading
GardaWorld Finalizes Successful Credit Facility Enhancements

Updated Category News Views 124

GardaWorld's Strategic Credit Facility Enhancements MONTREAL / -- Garda World Security Corporation, known as GardaWorld, is making significant strides in its operational efficiency and financial management. This entrepreneurial-driven company specializes in security services and innovative risk solutions. Recently, GardaWorld has successfully completed amendments to its...

Continue Reading
Transformative Trends in eCommerce: The Future of Marketing

Updated Category News Views 361

Understanding the Future of eCommerce Marketing As we approach a pivotal moment in the eCommerce realm, it's essential to recognize the trends that are not only shaping the industry today but are also setting the stage for 2025. The digital marketplace is evolving rapidly, and organizations must adapt to thrive. Based on insights shared by leading experts, including CEO...

Continue Reading
OSE Immunotherapeutics Reveals Strategic Innovations for Growth

Updated Category News Views 238

OSE Immunotherapeutics Shapes Future with 2026-2028 Strategic Vision OSE Immunotherapeutics has unveiled an ambitious strategic plan aimed at enhancing its product offerings and maximizing shareholder value. This plan is designed for the upcoming three years and spans innovative treatments and strategic initiatives that promise to propel the company forward in the...

Continue Reading